WGU D116 ADVANCED PHARMACOLOGY OA EXAM PRACTICE | STUDY GUIDE |
TESTBANK | PRACTICE QUESTIONS & ANSWERS | EXAM PREPARATION |
COMPREHENSIVE PRACTICE EXAM | LATEST UPDATE 2026/2027 | ADVANCED
REVIEW
Examiner:
Western Governors University (WGU)
TABLE OF CONTENTS
1. Principles of Advanced Pharmacology
2. Pharmacokinetics and Pharmacodynamics
3. Pharmacogenomics and Precision Medicine
4. Autonomic Nervous System Pharmacology
5. Cardiovascular Pharmacotherapeutics
6. Endocrine Pharmacology
7. Anti-Infective Pharmacology
8. Neurologic and Psychiatric Pharmacology
9. Pain Management and Controlled Substances
10. Respiratory Pharmacology
11. Gastrointestinal Pharmacology
12. Renal Pharmacology
13. Women's and Men's Health Pharmacology
14. Pediatric and Geriatric Pharmacology
15. Drug Interactions and Adverse Drug Events
16. Evidence-Based Prescribing
17. Clinical Decision-Making and Patient Safety
18. Ethical and Legal Considerations in Pharmacotherapy
DESCRIPTION
This comprehensive practice question set is designed to reinforce advanced
pharmacology concepts commonly covered in graduate-level nursing and advanced
clinical pharmacology coursework. The questions emphasize application of
pharmacokinetic and pharmacodynamic principles, patient-specific prescribing
decisions, adverse drug reaction management, pharmacogenomics, drug interactions,
and evidence-based therapeutic selection across multiple body systems. Learners will
,encounter challenging clinical scenarios requiring critical analysis, prioritization, and
professional judgment rather than simple memorization. These questions are
intended solely as an educational study resource based on commonly taught
pharmacology topics and widely used study materials. They are not actual
examination questions and are designed to strengthen clinical reasoning, improve
medication safety knowledge, and enhance readiness for advanced pharmacology
assessments.
QUESTION 1.
A 72-year-old patient with chronic kidney disease (estimated GFR 28 mL/min/1.73
m²) is prescribed a medication that is primarily eliminated unchanged through the
kidneys. Which prescribing action best minimizes the risk of drug accumulation
while maintaining therapeutic efficacy?
A. Reduce the maintenance dose or extend the dosing interval based on renal
function.
B. Increase the loading dose and maintain the usual dosing interval.
C. Continue the standard dosage because age alone does not influence clearance.
D. Substitute the medication with another agent solely because the patient is older.
🔴 Correct Answer: A. Reduce the maintenance dose or extend the dosing
interval based on renal function.
🔵 Explanation: Maintenance dosing should be adjusted when renal clearance is
substantially reduced to prevent accumulation and toxicity. A loading dose is often
based on volume of distribution rather than clearance, making option B
inappropriate. Age alone is not the determining factor, but impaired renal function is.
Substitution is not automatically required if appropriate dose adjustment can achieve
safe therapy.
QUESTION 2.
A patient taking warfarin begins therapy with trimethoprim-sulfamethoxazole.
Which management strategy best reflects evidence-based prescribing?
,A. Continue both medications without monitoring because the interaction is
clinically insignificant.
B. Increase the warfarin dose to offset antibiotic effects.
C. Anticipate increased anticoagulation and arrange closer INR monitoring with
possible warfarin dose reduction.
D. Discontinue warfarin permanently.
🔴 Correct Answer: C. Anticipate increased anticoagulation and arrange closer
INR monitoring with possible warfarin dose reduction.
🔵 Explanation: Trimethoprim-sulfamethoxazole inhibits warfarin metabolism and
can significantly increase INR and bleeding risk. Close laboratory monitoring and
individualized dose adjustment are preferred. The remaining options either ignore the
interaction or recommend inappropriate management.
QUESTION 3.
A patient with hypertension and diabetic nephropathy develops a persistent dry
cough several weeks after starting therapy. Which medication is the most likely
cause?
A. Hydrochlorothiazide
B. Enalapril
C. Amlodipine
D. Metoprolol
🔴 Correct Answer: B. Enalapril
🔵 Explanation: ACE inhibitors commonly produce a persistent dry cough because of
increased bradykinin levels. Thiazides, calcium channel blockers, and beta-blockers do
not typically produce this characteristic adverse effect. Recognition of class-specific
toxicity supports appropriate therapeutic substitution.
QUESTION 4.
, A patient with atrial fibrillation requires initiation of digoxin. Which factor most
significantly increases the risk of digoxin toxicity despite standard dosing?
A. Mild obesity
B. Controlled hypothyroidism
C. Hypercalcemia with preserved renal function
D. Declining renal function
🔴 Correct Answer: D. Declining renal function
🔵 Explanation: Digoxin is primarily eliminated by the kidneys, making reduced renal
function a major determinant of toxicity risk. Although electrolyte abnormalities may
contribute, impaired renal clearance has the greatest influence on drug accumulation.
Appropriate dose adjustment and monitoring are essential.
QUESTION 5.
A patient receiving insulin therapy experiences recurrent early morning
hyperglycemia despite normal bedtime glucose values. Continuous glucose
monitoring demonstrates nocturnal hypoglycemia followed by rebound
hyperglycemia. Which phenomenon best explains this pattern?
A. Dawn phenomenon
B. Somogyi effect
C. Insulin resistance syndrome
D. Postprandial glucose excursion
🔴 Correct Answer: B. Somogyi effect
🔵 Explanation: The Somogyi effect refers to rebound hyperglycemia following
unrecognized nocturnal hypoglycemia triggered by counterregulatory hormones. The
dawn phenomenon occurs without preceding hypoglycemia. Differentiating these
conditions guides appropriate insulin adjustment.
QUESTION 6.
TESTBANK | PRACTICE QUESTIONS & ANSWERS | EXAM PREPARATION |
COMPREHENSIVE PRACTICE EXAM | LATEST UPDATE 2026/2027 | ADVANCED
REVIEW
Examiner:
Western Governors University (WGU)
TABLE OF CONTENTS
1. Principles of Advanced Pharmacology
2. Pharmacokinetics and Pharmacodynamics
3. Pharmacogenomics and Precision Medicine
4. Autonomic Nervous System Pharmacology
5. Cardiovascular Pharmacotherapeutics
6. Endocrine Pharmacology
7. Anti-Infective Pharmacology
8. Neurologic and Psychiatric Pharmacology
9. Pain Management and Controlled Substances
10. Respiratory Pharmacology
11. Gastrointestinal Pharmacology
12. Renal Pharmacology
13. Women's and Men's Health Pharmacology
14. Pediatric and Geriatric Pharmacology
15. Drug Interactions and Adverse Drug Events
16. Evidence-Based Prescribing
17. Clinical Decision-Making and Patient Safety
18. Ethical and Legal Considerations in Pharmacotherapy
DESCRIPTION
This comprehensive practice question set is designed to reinforce advanced
pharmacology concepts commonly covered in graduate-level nursing and advanced
clinical pharmacology coursework. The questions emphasize application of
pharmacokinetic and pharmacodynamic principles, patient-specific prescribing
decisions, adverse drug reaction management, pharmacogenomics, drug interactions,
and evidence-based therapeutic selection across multiple body systems. Learners will
,encounter challenging clinical scenarios requiring critical analysis, prioritization, and
professional judgment rather than simple memorization. These questions are
intended solely as an educational study resource based on commonly taught
pharmacology topics and widely used study materials. They are not actual
examination questions and are designed to strengthen clinical reasoning, improve
medication safety knowledge, and enhance readiness for advanced pharmacology
assessments.
QUESTION 1.
A 72-year-old patient with chronic kidney disease (estimated GFR 28 mL/min/1.73
m²) is prescribed a medication that is primarily eliminated unchanged through the
kidneys. Which prescribing action best minimizes the risk of drug accumulation
while maintaining therapeutic efficacy?
A. Reduce the maintenance dose or extend the dosing interval based on renal
function.
B. Increase the loading dose and maintain the usual dosing interval.
C. Continue the standard dosage because age alone does not influence clearance.
D. Substitute the medication with another agent solely because the patient is older.
🔴 Correct Answer: A. Reduce the maintenance dose or extend the dosing
interval based on renal function.
🔵 Explanation: Maintenance dosing should be adjusted when renal clearance is
substantially reduced to prevent accumulation and toxicity. A loading dose is often
based on volume of distribution rather than clearance, making option B
inappropriate. Age alone is not the determining factor, but impaired renal function is.
Substitution is not automatically required if appropriate dose adjustment can achieve
safe therapy.
QUESTION 2.
A patient taking warfarin begins therapy with trimethoprim-sulfamethoxazole.
Which management strategy best reflects evidence-based prescribing?
,A. Continue both medications without monitoring because the interaction is
clinically insignificant.
B. Increase the warfarin dose to offset antibiotic effects.
C. Anticipate increased anticoagulation and arrange closer INR monitoring with
possible warfarin dose reduction.
D. Discontinue warfarin permanently.
🔴 Correct Answer: C. Anticipate increased anticoagulation and arrange closer
INR monitoring with possible warfarin dose reduction.
🔵 Explanation: Trimethoprim-sulfamethoxazole inhibits warfarin metabolism and
can significantly increase INR and bleeding risk. Close laboratory monitoring and
individualized dose adjustment are preferred. The remaining options either ignore the
interaction or recommend inappropriate management.
QUESTION 3.
A patient with hypertension and diabetic nephropathy develops a persistent dry
cough several weeks after starting therapy. Which medication is the most likely
cause?
A. Hydrochlorothiazide
B. Enalapril
C. Amlodipine
D. Metoprolol
🔴 Correct Answer: B. Enalapril
🔵 Explanation: ACE inhibitors commonly produce a persistent dry cough because of
increased bradykinin levels. Thiazides, calcium channel blockers, and beta-blockers do
not typically produce this characteristic adverse effect. Recognition of class-specific
toxicity supports appropriate therapeutic substitution.
QUESTION 4.
, A patient with atrial fibrillation requires initiation of digoxin. Which factor most
significantly increases the risk of digoxin toxicity despite standard dosing?
A. Mild obesity
B. Controlled hypothyroidism
C. Hypercalcemia with preserved renal function
D. Declining renal function
🔴 Correct Answer: D. Declining renal function
🔵 Explanation: Digoxin is primarily eliminated by the kidneys, making reduced renal
function a major determinant of toxicity risk. Although electrolyte abnormalities may
contribute, impaired renal clearance has the greatest influence on drug accumulation.
Appropriate dose adjustment and monitoring are essential.
QUESTION 5.
A patient receiving insulin therapy experiences recurrent early morning
hyperglycemia despite normal bedtime glucose values. Continuous glucose
monitoring demonstrates nocturnal hypoglycemia followed by rebound
hyperglycemia. Which phenomenon best explains this pattern?
A. Dawn phenomenon
B. Somogyi effect
C. Insulin resistance syndrome
D. Postprandial glucose excursion
🔴 Correct Answer: B. Somogyi effect
🔵 Explanation: The Somogyi effect refers to rebound hyperglycemia following
unrecognized nocturnal hypoglycemia triggered by counterregulatory hormones. The
dawn phenomenon occurs without preceding hypoglycemia. Differentiating these
conditions guides appropriate insulin adjustment.
QUESTION 6.
